• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Craig A. Bunnell, M.D. M.P.H.

Assistant Professor, Department of Medicine, Harvard Medical School

Physician, Breast Oncology Center, Dana-Farber Cancer Institute

Contact Info

Craig Bunnell
Dana-Farber Cancer Institute
44 Binney Street
Boston, MA, 02115
Mailstop: Dana 1210
Phone: 617-632-3800
Fax: 617-632-1930
Email not available

Assistant

Kelly Chisholm
Assistant Professor of Medicine
Breast Oncology Center
Dana-Farber Cancer Institute
44 Binney Street
Boston, MA, 02115
Mailstop: Dana 1210
Phone: 617-632-3800
Fax: 617-632-1930
kchisholm@partners.org

DF/HCC Program Affiliation

Translational Pharmacology and Early Therapeutic Trials
Breast Cancer

Research Abstract

Research interests focus on development of new drugs and oral chemotherapeutic agents as well as issues of symptom control and quality of life.

Publications

  • Carlson RW, Moench SJ, Hammond ME, Perez EA, Burstein HJ, Allred DC, Vogel CL, Goldstein LJ, Somlo G, Gradishar WJ, Hudis CA, Jahanzeb M, Stark A, Wolff AC, Press MF, Winer EP, Paik S, Ljung BM,.HER2 testing in breast cancer: NCCN Task Force report and re
    16813731
  • Burstein HJ, Bellon JR, Galper S, Lu HM, Kuter I, Taghian AG, Wong J, Gelman R, Bunnell CA, Parker LM, Garber JE, Winer EP, Harris JR, Powell SN.Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophos
    16243442
  • Bunnell CA, Winer EP.Oral 5-FU analogues in the treatment of breast cancer.Oncology (Huntingt) 1998 Oct;12(10 Suppl 7):39-43.
    9830624